Lisa Deschamps - 02 Nov 2021 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Claire Poll, Attorney-in-fact for Lisa Deschamps
Issuer symbol
VRNA
Transactions as of
02 Nov 2021
Net transactions value
-$7,690
Form type
4
Filing time
03 Nov 2021, 19:53:50 UTC
Previous filing
10 Aug 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Sale $7,690 -11,672 -12% $0.6588* 81,984 02 Nov 2021 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
F3 The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
F4 Consists of (i) 29,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 3,625 ADSs); and (ii) 52,984 Ordinary Shares underlying 6,623 ADSs.